NovaBay Pharmaceuticals (AMEX:NBY) Stock Quotes, Forecast and News Summary

Q: What sector and industry does NovaBay Pharmaceuticals (NBY) operate in?

NovaBay Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.

NovaBay Pharmaceuticals Stock (AMEX: NBY) stock price, news, charts, stock research, profile.

Open	$0.74
Close	$0.71
Volume / Avg.	93.62K / 2.77M
Day Range	$0.69 - $0.74
52 Wk Range	0.36 - 12.08
Market Cap	$3.48M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	51
Short Interest	15.65%
Days to Cover	1

Recent News

What's Going On With NovaBay Pharmaceuticals Shares Friday?

NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals.

Dylan Berman

What's Going On With NovaBay Pharmaceuticals (NBY) Stock?

NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of its public offering.

Henry Khederian

S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.74
Close	$0.71
Volume / Avg.	93.62K / 2.77M
Day Range	$0.69 - $0.74
52 Wk Range	0.36 - 12.08
Market Cap	$3.48M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	51
Short Interest	15.65%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NovaBay Pharmaceuticals (NBY) stock?

You can purchase shares of NovaBay Pharmaceuticals (AMEX:NBY) through any online brokerage.

View our list of the best stock brokerages

Who are NovaBay Pharmaceuticals (NBY) competitors?

Other companies in NovaBay Pharmaceuticals’s space includes: 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN), Universe Pharmaceuticals (NASDAQ:UPC), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).

What is the forecast, or price target, for NovaBay Pharmaceuticals (NBY) stock?

NovaBay Pharmaceuticals has a consensus price target of $2.32.

What is the current price for NovaBay Pharmaceuticals (NBY)?

The stock price for NovaBay Pharmaceuticals (AMEX: NBY) is $0.7128 last updated November 15, 2024 at 8:00 PM EST.

Does NovaBay Pharmaceuticals (NBY) pay a dividend?

There are no upcoming dividends for NovaBay Pharmaceuticals.

When is NovaBay Pharmaceuticals (AMEX:NBY) reporting earnings?

NovaBay Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is NovaBay Pharmaceuticals (NBY) going to split?

There is no upcoming split for NovaBay Pharmaceuticals.

What sector and industry does NovaBay Pharmaceuticals (NBY) operate in?

NovaBay Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.

Comments

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals (NBY) Forecast